Synchron

Synchron raises $308m to leapfrog Neuralink – with $54m from Australian taxpayer

Once a Melbourne university spin-out, now a billion-dollar U.S. medtech, Synchron has secured $308 million to accelerate brain-computer interfaces — and Australia’s government is paying to bring it home. Key Takeaways Key Background Synchron’s brain computer interface was developed by founders Tom Oxley, a neurologist and brain surgeon, and Nick Opie, a professor of bio-medical […]

Hullbot

Hullbot raises $16m from the bottom of the harbour

Sydney-based Hullbot, maker of autonomous underwater robots that scrub ship hulls, has raised $16 million in a Series A round led by climate-focused funds. Key Takeaways Key Background Hullbot CEO Tom Loefler founded the company based on recognising that biofouling was a persistent, costly problem in global shipping. Traditionally, vessels are cleaned infrequently in dry […]

Anduril

Submarines and Silicon Valley: Inside Anduril’s Australian gambit

Anduril, the company that opened a submarine factory in Sydney today, sits somewhere between a sovereign capability saviour and a sci-fi character. Anduril’s Asia Pacific CEO David Goodrich asked his board to start building a submarine factory in Sydney 18 months before any contract was signed. “I had a lot of sleepless nights,” he says […]

From start-ups to super mansions: Brad Moran’s big Tallai bet

Brad Moran has applied the same lessons he picked up as an AFL footy player and start-up founder to property redevelopment, the culmination being a Queensland mega-mansion built to delight.  This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your copy. “What I have is a very stimulated brain that […]

Why Australia’s biggest firms are buying ideas instead of building them

Innovation isn’t always born in a laboratory – it can be bought off the shelf. Data journalist Juliette O’Brien shows how companies with deep pockets are skipping the long grind of research and development by acquiring ready-made ideas, teams and technologies.  This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure […]

Longer leash on life: Inside the dog longevity startup

What if dogs could live longer and healthier lives? Loyal’s Celine Halioua has raised $135 million from top investors to develop canine longevity pills—and expects to get her first conditional approval from the FDA next year. This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your copy. Dogs don’t live […]

How Square Peg’s Paul Bassat is picking the next AI giants

SEEK co-founder Paul Bassat built Square Peg into a venture capital powerhouse. His latest bets are on AI, Thinking Machines Lab, and the non-partisan Amplify, which tackles housing and equity challenges.    This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your copy. Paul Bassat’s 2025 investment in Mira Murati’s $18.5 […]

Inside Antler’s £100 million revival plan

Once stripped back to a dormant website, Antler is now reclaiming its place in the $86 billion luggage industry, guided by heritage rather than hype. This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your copy. Among the glamorous luggage spinning endlessly on airport carousels, the competition has never been […]

How this new biotech billionaire outmanoeuvred Merck in China

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best seller–and its surging stock just made her a billionaire. This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your […]